Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Digital and AI

 

HBI 2026: Investing in Emerging Markets Summit in partnership with the IFC

At HBI 2026, healthcare executives and investors highlighted both the opportunities and the operational complexity involved in succeeding in emerging markets during the Investing in Emerging Markets Summit, held in partnership with the International Finance Corporation (IFC), a development bank which is part of the World Bank Group.
May 21, 2026

Isomorphic Labs raises $2.1bn 

Isomorphic Labs, a London-based AI drug design and development company, has raised $2.1 billion in funding led by American venture capital firm Thrive Capital. Google Ventures. Tech giant Alphabet's independent venture capital arm, alongside specialist technology investment firm MGX, global investment firm Temasek, Alphabet's independent growth equity fund CapitalG, and the UK Sovereign AI Fund, the British government’s £500 million ($670.32 mn) venture fund, also invested in the firm.
May 21, 2026

GHO and CBC merging to form world’s largest specialist healthcare PE firm with $21bn AUM

London-based healthcare-focused private equity (PE) firm GHO (Global Healthcare Opportunities) Capital is merging with Asia’s largest healthcare-focused private markets investor, Singapore-based CBC Group. Once completed the merged entity will be the largest specialist healthcare PE firm in the world, with over $21 billion assets under management (AUM) across medical devices, pharma, diagnostics, healthcare infrastructure, and healthcare IT.
May 21, 2026

Roche acquires PathAI for ~$1.05 billion

Swiss-based multinational healthcare company Roche has agreed to acquire PathAI, a US-based AI-powered digital pathology firm, for ~$1.05 billion. Roche will pay $750 million upfront and additional milestone payments of up to $300 million.
May 14, 2026

Carlyle acquires Knack RCM and EqualizeRCM

US private equity firm Carlyle has acquired a majority stake in two healthcare revenue cycle management (RCM) platforms: Knack RCM and EqualizeRCM. The investment is being made through Carlyle Asia Partners VI and Carlyle Asia Partners Growth II.
May 7, 2026

FutureLife partners with Alife Health

FutureLife, a pan-European IVF and genetics provider, has rolled out an AI platform across its 60 clinics in 16 countries through a partnership with US-based Alife Health, which modernises and personalises the IVF process using AI.
May 7, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us